文献
J-GLOBAL ID:201702264232240019
整理番号:17A1818812
phosphoarrayプラットフォームは頭頸部癌におけるパーソナライズキナーゼ阻害剤治療が可能である【Powered by NICT】
A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers
著者 (7件):
Klinghammer Konrad
(Department of Hematology and Oncology, Charite University Medicine, Berlin, Germany)
,
Keller James
(Department of Microbiology and Molecular Genetics, Stony Brook University, Stony Brook, NY, 11794)
,
George Jonathan
(Department of Microbiology and Molecular Genetics, Stony Brook University, Stony Brook, NY, 11794)
,
Hoffmann Jens
(EPO-Experimental Pharmacology and Oncology GmbH, Berlin, Germany)
,
Chan Edward L.
(Department of Microbiology and Molecular Genetics, Stony Brook University, Stony Brook, NY, 11794)
,
Chan Edward L.
(Division of Pediatric Hematology/Oncology)
,
Hayman Michael J.
(Department of Microbiology and Molecular Genetics, Stony Brook University, Stony Brook, NY, 11794)
資料名:
International Journal of Cancer
(International Journal of Cancer)
巻:
142
号:
1
ページ:
156-164
発行年:
2018年
JST資料番号:
A0267B
ISSN:
0020-7136
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)